The 340B PATIENTS Act of 2025 aims to ensure accessibility of drugs through the drug discount program under section 340B of the Public Health Service.
The 340B PATIENTS Act of 2025 amends section 340B of the Public Health Service Act to clarify that drug manufacturers must offer discounted prices on covered outpatient drugs to covered entities participating in the program, regardless of the manner or location in which the drug is dispensed. It prohibits drug manufacturers from placing conditions on the ability of covered entities to purchase covered outpatient drugs.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.